ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,928,522 | +6.1% | 1,967,879 | +50.5% | 0.00% | – |
| Q2 2023 | $1,817,359 | -76.3% | 1,307,452 | -72.9% | 0.00% | – |
| Q1 2023 | $7,668,869 | -77.7% | 4,823,188 | -12.5% | 0.00% | -100.0% |
| Q4 2022 | $34,322,235 | +12.4% | 5,509,187 | +20.9% | 0.00% | 0.0% |
| Q3 2022 | $30,542,000 | +11.8% | 4,558,644 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $27,311,000 | +56.4% | 4,294,232 | +14.1% | 0.00% | – |
| Q1 2022 | $17,463,000 | +55.9% | 3,763,740 | +67.9% | 0.00% | – |
| Q4 2021 | $11,204,000 | -53.7% | 2,241,217 | +11.7% | 0.00% | -100.0% |
| Q3 2021 | $24,173,000 | -45.2% | 2,006,134 | -3.8% | 0.00% | 0.0% |
| Q2 2021 | $44,105,000 | -26.7% | 2,085,347 | -2.8% | 0.00% | -50.0% |
| Q1 2021 | $60,208,000 | +12.2% | 2,146,396 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $53,669,000 | -28.7% | 2,064,205 | +1.9% | 0.00% | -33.3% |
| Q3 2020 | $75,293,000 | -29.8% | 2,025,704 | -3.0% | 0.00% | -25.0% |
| Q2 2020 | $107,181,000 | +74.0% | 2,088,896 | +6.9% | 0.00% | +33.3% |
| Q1 2020 | $61,610,000 | -50.0% | 1,953,987 | -5.5% | 0.00% | -40.0% |
| Q4 2019 | $123,329,000 | +59.1% | 2,068,232 | -2.2% | 0.01% | +66.7% |
| Q3 2019 | $77,540,000 | -16.0% | 2,115,163 | +6.6% | 0.00% | -25.0% |
| Q2 2019 | $92,270,000 | +23.7% | 1,983,420 | +6.8% | 0.00% | +33.3% |
| Q1 2019 | $74,585,000 | -13.7% | 1,857,673 | -1.1% | 0.00% | -25.0% |
| Q4 2018 | $86,430,000 | +3.7% | 1,878,899 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $83,367,000 | +17.8% | 1,878,905 | +4.1% | 0.00% | +33.3% |
| Q2 2018 | $70,746,000 | -34.3% | 1,805,232 | +21.3% | 0.00% | -40.0% |
| Q1 2018 | $107,671,000 | +8.6% | 1,488,597 | -1.1% | 0.01% | 0.0% |
| Q4 2017 | $99,114,000 | +30.0% | 1,505,395 | -1.1% | 0.01% | +25.0% |
| Q3 2017 | $76,267,000 | +28.9% | 1,521,674 | +19.0% | 0.00% | +33.3% |
| Q2 2017 | $59,154,000 | +30.7% | 1,278,206 | -0.3% | 0.00% | +50.0% |
| Q1 2017 | $45,265,000 | +110302.4% | 1,281,944 | +39211.4% | 0.00% | – |
| Q4 2016 | $41,000 | -12.8% | 3,261 | -4.1% | 0.00% | – |
| Q3 2016 | $47,000 | +38.2% | 3,401 | 0.0% | 0.00% | – |
| Q2 2016 | $34,000 | +126.7% | 3,401 | +285.2% | 0.00% | – |
| Q1 2016 | $15,000 | +87.5% | 883 | +134.2% | 0.00% | – |
| Q4 2015 | $8,000 | -11.1% | 377 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -71.0% | 377 | 0.0% | 0.00% | – |
| Q2 2015 | $31,000 | -93.0% | 377 | -92.1% | 0.00% | -100.0% |
| Q1 2015 | $443,000 | – | 4,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |